Anglo-Swedish drugmaker AstraZeneca entered into a collaboration and investment agreement with Cellectis, a French clinical-stage biotechnology company, to accelerate the...
31.01.2014
- Bayer CropScience has signed two new agreements extending its existing R&D partnership with U.S. plant sciences company Cellectis to introduce targeted modifications to selected...
